Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 33, pages 243–245 (2004)Cite this article

Summary:

A 55-year-old man with acute myeloid leukemia in second relapse presented 4 months after haploidentical CD34+-selected hematopoietic stem cell transplantation (HSCT) with symmetric, progressive neurological deficits of the lower extremities. Although there was no molecular evidence for drug resistance in the cerebral-spinal fluid, antiviral combination therapy failed to control the rapidly progressing CMV polyradiculopathy (PRP) and encephalitis, which were confirmed by autopsy studies. Late CMV PRP as an unusual manifestation of CMV disease should be kept in mind in patients with suggestive neurological symptoms after HSCT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Boeckh M, Riddel SR, Cunninham T et al. Increased incidence of late CMV disease in allogeneic marrow transplant recipients after ganciclovir prophylaxis is due to a lack of CMV specific T cell responses. Blood 1996; 88 (Suppl 1): 302a.

    Google Scholar 

  2. Seo SK, Regan A, Cihlar T et al. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clin Infect Dis 2001; 33: 105–108.

    Article  Google Scholar 

  3. Wolf DG, Lurain NS, Zuckerman T et al. Emerge of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 2003; 101: 463–465.

    Article  CAS  Google Scholar 

  4. Anders HJ, Goebel FD . Cytomegalovirus polyradiculopathy in patients with AIDS. Clin Infect Dis 1998; 27: 345–352.

    Article  CAS  Google Scholar 

  5. Cesaro S, Gazzola MV, Marson P et al. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. Am J Hematol 2003; 72: 143–146.

    Article  Google Scholar 

  6. Meyer-König U, Serr A, Hufert FT et al. Laboratory diagnosis of HCMV-related disease in renal transplant patients – pp65 antigen detection vs nested PCR. Clin Diag Virol 1995; 3: 49.

    Article  Google Scholar 

  7. Michel D, Höhn S, Haller T et al. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. J Med Virol 2001; 65: 70–76.

    Article  CAS  Google Scholar 

  8. Arribas JR, Storch GA, Clifford DB et al. Cytomegalovirus encephalitis. Ann Intern Med 1996; 125: 577–587.

    Article  CAS  Google Scholar 

  9. Li CR, Greenberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971–1979.

    CAS  Google Scholar 

  10. Boeckh M, Leisenring W, Riddell SR et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101: 407–414.

    Article  CAS  Google Scholar 

  11. Fletcher C, Sawchuk R, Chinnock B et al. Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther 1986; 40: 281–286.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

CMV genotype analysis was done by Dr D Michel, University Hospital Ulm, Germany.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, University of Freiburg, Germany

    R Zeiser, C Grüllich, H Bertz & J Finke

  2. Department of Neuropathology, University of Freiburg, Germany

    G Pantazis

  3. Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Germany

    F T Hufert

  4. Department of Radiology, University of Freiburg, Germany

    T A Bley

Authors
  1. R Zeiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Grüllich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Pantazis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F T Hufert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T A Bley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Finke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Zeiser.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zeiser, R., Grüllich, C., Bertz, H. et al. Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation. Bone Marrow Transplant 33, 243–245 (2004). https://doi.org/10.1038/sj.bmt.1704311

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704311

Keywords

  • haploidentical
  • CD34+-selected
  • hematopoietic stem cell transplantation
  • cytomegalovirus
  • polyradiculopathy

This article is cited by

Search

Advanced search

Quick links